CN Patent
CN111620880B — Pf-06651600 dl-酒石酸盐,晶型及其制备方法
Assigned to Jiangsu Ailikang Pharmaceutical Technology Co ltd · Expires 2022-06-10 · 4y expired
What this patent protects
本发明提供了PF‑06651600 DL‑酒石酸盐,晶型及其制备方法。具体的,本发明涉及PF‑06651600 DL‑酒石酸盐的晶型及其制备方法,所得到的PF‑06651600 DL‑酒石酸盐及其晶型具有很好的稳定性、水溶性、不易吸湿性,便于储存和运输,为提高PF‑06651600成药性并具有更好的储存稳定性提供了可能。
USPTO Abstract
本发明提供了PF‑06651600 DL‑酒石酸盐,晶型及其制备方法。具体的,本发明涉及PF‑06651600 DL‑酒石酸盐的晶型及其制备方法,所得到的PF‑06651600 DL‑酒石酸盐及其晶型具有很好的稳定性、水溶性、不易吸湿性,便于储存和运输,为提高PF‑06651600成药性并具有更好的储存稳定性提供了可能。
Drugs covered by this patent
- Litfulo (Ritlecitinib Tosylate) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.